CRL 195.04 (-1.38%)
US1598641074• Medical Diagnostics & Research• Diagnostics & Research
Intro Stories Numbers Peers
  1. Home
  2. /
  3. All Stocks
  4. /
  5. CRL

Charles River Laboratories (CRL) Competitor Comparison

We are evaluating the key criteria listed to compare Charles River Laboratories (CRL) against its competitors in the Diagnostics & Research industry.

Market Capitalization

14 / 58

Gross Profits

15 / 52

Total Revenue

10 / 57

EBITDA

12 / 56

Free Cashflow

13 / 56

Quick Ratio

45 / 57

Earnings per Share

7 / 56

Dividend yield

0 / 8

Total Cash

28 / 57

Performance 3 years

29 / 58

Performance 5 years

20 / 58

Performance 10 years

18 / 58

Linearity 3 years

27 / 58

Linearity 5 years

16 / 58

Linearity 10 years

39 / 58

Total Rank

2 / 58

Dividend Rank

19 / 58

Valuation Rank

1 / 58

Piotroski Rank

5 / 58

Muliplier Rank

17 / 58

Linearity 5 years - CRL ranking 16 / 58

These are the competitors of Charles River Laboratories in the industry Diagnostics & Research ranked by linearity 5 years
1. Co-Diagnostics CODX
52.22
2. Ortho Clinical Diagnostics Holdings OCDX
33.4
3. DarioHealth DRIO
31.71
4. CareDx CDNA
29.25
5. Syneos Health SYNH
24.79
6. Heska HSKA
15.42
7. Inotiv NOTV
10.22
8. Trinity Biotech TRIB
9.61
9. Pacific Biosciences of California PACB
9.27
10. Exact Sciences EXAS
9.02
11. NeoGenomics NEO
8.81
12. Anixa Biosciences ANIX
8.74
13. Olink Holding OLK
8.53
14. Fulgent Genetics FLGT
8.39
15. Aspira Womens Health AWH
5.9
16. Charles River Laboratories CRL
5.89
17. Myriad Genetics MYGN
5.8
18. Qiagen QGEN
5.58
19. DexCom DXCM
5.23
20. PerkinElmer PKI
4.97
21. Laboratory Corp of America Holdings LH
4.44
22. Quest Diagnostics DGX
4.43
23. Sotera Health SHC
4.32
24. Illumina ILMN
4.22
25. Personalis PSNL
4.16
26. Neogen NEOG
4.13
27. Twist Bioscience TWST
4.1
28. Guardant Health GH
3.86
29. IDEXX Laboratories IDXX
3.81
30. IQVIA Holdings IQV
3.65
31. Bioventus BVS
3.51
32. Sera Prognostics SERA
3.48
33. Waters WAT
3.45
34. National Research NRC
3.42
35. Enzo Biochem ENZ
3.19
36. Agilent Technologies A
3.02
37. Psychemedics PMD
2.67
38. Interpace Biosciences IDXG
2.63
39. Mettler-Toledo MTD
2.62
40. Exagen XGN
2.53
41. Precipio PRPO
2.35
42. Thermo Fisher Scientific TMO
2.31
43. Neuronetics STIM
2.28
44. Global Cord Blood CO
2.23
45. Icon ICLR
2.09
46. MaxCyte MXCT
2.07
47. MDxHealth MDXH
2.04
48. Biodesix BDSX
1.96
49. Danaher DHR
1.91
50. Prenetics Global PRE
1.83
51. bioAffinity Technologies BIAF
1.67
52. Organovo Holdings ONVO
1.6
53. SeqLL SQL
1.38
54. Meridian Bioscience VIVO
0.99
55. Natera NTRA
0.8
56. Medpace Holdings MEDP
0.51
57. RadNet RDNT
0.36
58. Lantheus Holdings LNTH
0.24
Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.